Clinical Research Directory
Browse clinical research sites, groups, and studies.
Jafron Cytokine Adsorber During Pediatric Open-Heart Surgeries
Sponsor: Centre Hospitalier Universitaire Vaudois
Summary
This prospective single-center randomized controlled trial aims at evaluating the safety and feasibility of an hemoadsorption protocol using Jafron HA-60 during cardio-pulmonary bypass in 20 pediatric patients undergoing open-heart surgery.
Key Details
Gender
All
Age Range
Any - 10 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-03
Completion Date
2029-04
Last Updated
2026-02-10
Healthy Volunteers
No
Conditions
Interventions
Hemoadsorption
The hemoadsorption treatment will be performed during the entire duration of the CPB. The blood flow within the hemoadsorber will be controlled and set to 7% of the theoretical minimal CPB flow which is calculated as 2.5 L/min/1.73m2 of body surface area.
Locations (1)
Centre Hospitalier Universitaire Vaudois (CHUV)
Lausanne, Canton of Vaud, Switzerland